 |
PDBsum entry 3jxj
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Membrane protein
|
PDB id
|
|
|
|
3jxj
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nat Genet
42:170-174
(2010)
|
|
PubMed id:
|
|
|
|
|
| |
|
Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C.
|
|
G.Landouré,
A.A.Zdebik,
T.L.Martinez,
B.G.Burnett,
H.C.Stanescu,
H.Inada,
Y.Shi,
A.A.Taye,
L.Kong,
C.H.Munns,
S.S.Choo,
C.B.Phelps,
R.Paudel,
H.Houlden,
C.L.Ludlow,
M.J.Caterina,
R.Gaudet,
R.Kleta,
K.H.Fischbeck,
C.J.Sumner.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Charcot-Marie-Tooth disease type 2C (CMT2C) is an autosomal dominant neuropathy
characterized by limb, diaphragm and laryngeal muscle weakness. Two unrelated
families with CMT2C showed significant linkage to chromosome 12q24.11. We
sequenced all genes in this region and identified two heterozygous missense
mutations in the TRPV4 gene, C805T and G806A, resulting in the amino acid
substitutions R269C and R269H. TRPV4 is a well-known member of the TRP
superfamily of cation channels. In TRPV4-transfected cells, the CMT2C mutations
caused marked cellular toxicity and increased constitutive and activated channel
currents. Mutations in TRPV4 were previously associated with skeletal
dysplasias. Our findings indicate that TRPV4 mutations can also cause a
degenerative disorder of the peripheral nerves. The CMT2C-associated mutations
lie in a distinct region of the TRPV4 ankyrin repeats, suggesting that this
phenotypic variability may be due to differential effects on regulatory
protein-protein interactions.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
(a) Quantification of TRPV4 transcript by qRT-PCR in control
human lymphoblast lines (n = 4), human dorsal spinal cord (n =
3), ventral spinal cord (n = 3) and tracheal cartilage (n = 3)
using primers specific for the following exon regions: exons
3–4, exons 5–6, exons 7–8, exon 5 and exon 7. Values are
normalized to the first tracheal cartilage sample. Data is
averaged; error bars, s.e.m. (b) DRG neurons were transfected
with wild-type and mutant forms of TRPV4 (green). At 16 h, some
cells expressing mutant forms of TRPV4 show evidence of early
cellular toxicity with a collapsed cytoplasm. The nuclear DAPI
stain is blue. Scale bar, 40 μm. (c) Quantification of
propidium iodide uptake in DRG neurons expressing wild-type and
mutant TRPV4 reveals a marked increase of cell toxicity in
mutant expressing cells at 48 h. *P < 0.0001. (d) HEK293 cells
expressing R269C and R269H mutants show an increase in the
number of dead cells (red channel is EthD-1 stain) at 48 h; this
increase is prevented by the TRP channel blocker ruthenium red
(RR). Green channel is calcein-AM stain for live cells. Scale
bar, 200 μm. (e) Quantification of cell death in HEK293 cells
indicates a time-dependent increase in cell death that is
blocked by the TRP channel blocker ruthenium red (RR). *P <
0.01, **P < 0.001. Data in c and e are averaged from three
independent experiments; error bars, s.e.m.
|
 |
Figure 4.
(a) Primary structure of the TRPV4 protein, with the
positions of the CMT2C-associated (Arg269; blue arrowhead) and
skeletal dysplasia–associated^6, ^7 (green arrowheads)
mutations indicated below. (b) Ribbon diagram of the chicken
Trpv4 ARD, with the location of the Arg269 residue (Arg255 in
chicken sequence) depicted as a blue sphere and the Ile331 and
Asp333 residues (Ile317 and Asp319 in chicken sequence,
respectively) previously shown to be mutated in skeletal
dysplasia as green spheres. (c) Surface representation of the
TRPV4 ARD with Arg269 in blue and Ile331 and Asp333 in green.
Residues that differ between chicken and human TRPV4 are yellow,
demonstrating that the palm and finger regions are conserved.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nat Genet
(2010,
42,
170-174)
copyright 2010.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Montell
(2011).
The history of TRP channels, a commentary and reflection.
|
| |
Pflugers Arch,
461,
499-506.
|
 |
|
|
|
|
 |
N.D.Merner,
P.A.Dion,
and
G.A.Rouleau
(2011).
Recent advances in the genetics of distal hereditary motor neuropathy give insight to a disease mechanism involving copper homeostasis that may extend to other motor neuron disorders.
|
| |
Clin Genet,
79,
23-34.
|
 |
|
|
|
|
 |
S.Ajroud-Driss,
H.X.Deng,
and
T.Siddique
(2011).
Recent advances in the genetics of hereditary axonal sensory-motor neuropathies type 2.
|
| |
Curr Neurol Neurosci Rep,
11,
262-273.
|
 |
|
|
|
|
 |
S.G.Lechner,
S.Markworth,
K.Poole,
E.S.Smith,
L.Lapatsina,
S.Frahm,
M.May,
S.Pischke,
M.Suzuki,
I.Ibañez-Tallon,
F.C.Luft,
J.Jordan,
and
G.R.Lewin
(2011).
The molecular and cellular identity of peripheral osmoreceptors.
|
| |
Neuron,
69,
332-344.
|
 |
|
|
|
|
 |
S.R.Lamandé,
Y.Yuan,
I.L.Gresshoff,
L.Rowley,
D.Belluoccio,
K.Kaluarachchi,
C.B.Little,
E.Botzenhart,
K.Zerres,
D.J.Amor,
W.G.Cole,
R.Savarirayan,
P.McIntyre,
and
J.F.Bateman
(2011).
Mutations in TRPV4 cause an inherited arthropathy of hands and feet.
|
| |
Nat Genet,
43,
1142-1146.
|
 |
|
|
|
|
 |
A.Z.Burakgazi,
and
A.Höke
(2010).
Respiratory muscle weakness in peripheral neuropathies.
|
| |
J Peripher Nerv Syst,
15,
307-313.
|
 |
|
|
|
|
 |
B.Nilius,
and
G.Owsianik
(2010).
Channelopathies converge on TRPV4.
|
| |
Nat Genet,
42,
98.
|
 |
|
|
|
|
 |
C.D.Wee,
L.Kong,
and
C.J.Sumner
(2010).
The genetics of spinal muscular atrophies.
|
| |
Curr Opin Neurol,
23,
450-458.
|
 |
|
|
|
|
 |
C.Goswami,
J.Kuhn,
P.A.Heppenstall,
and
T.Hucho
(2010).
Importance of non-selective cation channel TRPV4 interaction with cytoskeleton and their reciprocal regulations in cultured cells.
|
| |
PLoS One,
5,
e11654.
|
 |
|
|
|
|
 |
D.L.Guernsey,
H.Jiang,
K.Bedard,
S.C.Evans,
M.Ferguson,
M.Matsuoka,
C.Macgillivray,
M.Nightingale,
S.Perry,
A.L.Rideout,
A.Orr,
M.Ludman,
D.L.Skidmore,
T.Benstead,
and
M.E.Samuels
(2010).
Mutation in the gene encoding ubiquitin ligase LRSAM1 in patients with Charcot-Marie-Tooth disease.
|
| |
PLoS Genet,
6,
0.
|
 |
|
|
|
|
 |
J.Dai,
T.J.Cho,
S.Unger,
E.Lausch,
G.Nishimura,
O.H.Kim,
A.Superti-Furga,
and
S.Ikegawa
(2010).
TRPV4-pathy, a novel channelopathy affecting diverse systems.
|
| |
J Hum Genet,
55,
400-402.
|
 |
|
|
|
|
 |
M.Zimoń,
J.Baets,
M.Auer-Grumbach,
J.Berciano,
A.Garcia,
E.Lopez-Laso,
L.Merlini,
D.Hilton-Jones,
M.McEntagart,
A.H.Crosby,
N.Barisic,
E.Boltshauser,
C.E.Shaw,
G.Landouré,
C.L.Ludlow,
R.Gaudet,
H.Houlden,
M.M.Reilly,
K.H.Fischbeck,
C.J.Sumner,
V.Timmerman,
A.Jordanova,
and
P.D.Jonghe
(2010).
Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies.
|
| |
Brain,
133,
1798-1809.
|
 |
|
|
|
|
 |
R.Cregg,
A.Momin,
F.Rugiero,
J.N.Wood,
and
J.Zhao
(2010).
Pain channelopathies.
|
| |
J Physiol,
588,
1897-1904.
|
 |
|
|
|
|
 |
R.Raouf,
K.Quick,
and
J.N.Wood
(2010).
Pain as a channelopathy.
|
| |
J Clin Invest,
120,
3745-3752.
|
 |
|
|
|
|
 |
W.Everaerts,
X.Zhen,
D.Ghosh,
J.Vriens,
T.Gevaert,
J.P.Gilbert,
N.J.Hayward,
C.R.McNamara,
F.Xue,
M.M.Moran,
T.Strassmaier,
E.Uykal,
G.Owsianik,
R.Vennekens,
D.De Ridder,
B.Nilius,
C.M.Fanger,
and
T.Voets
(2010).
Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis.
|
| |
Proc Natl Acad Sci U S A,
107,
19084-19089.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |